UNIVERSAL VISION BIOTECHNOLOGY CO., LTD. Universal Vision Biotechnology Co., Ltd. Stock
Equities
3218
TW0003218004
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 245 TWD | +0.62% |
|
-5.77% | -11.55% |
| Sales 2024 * | 4.53B 139M | Sales 2025 * | 5.3B 163M | Capitalization | 20.76B 637M |
|---|---|---|---|---|---|
| Net income 2024 * | 1.15B 35.42M | Net income 2025 * | - | EV / Sales 2024 * | 4.11 x |
| Net cash position 2024 * | 2.12B 65.15M | Net cash position 2025 * | 2.55B 78.23M | EV / Sales 2025 * | 3.44 x |
| P/E ratio 2024 * |
18
x | P/E ratio 2025 * |
-
| Employees | 401 |
| Yield 2024 * |
3.44% | Yield 2025 * |
4.12% | Free-Float | 52.5% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +0.62% | ||
| 1 week | -5.77% | ||
| Current month | -9.76% | ||
| 1 month | -11.07% | ||
| 3 months | -12.97% | ||
| 6 months | -19.54% | ||
| Current year | -11.55% |
1 week
236.00
255.00
1 month
236.00277.00
Current year
236.00307.00
1 year
236.00412.74
3 years
198.11432.08
5 years
26.46432.08
10 years
16.26432.08
| Managers | Title | Age | Since |
|---|---|---|---|
Cheng Hung Lu
CEO | Chief Executive Officer | - | 10-01-31 |
Qiu Ju Hou
DFI | Director of Finance/CFO | - | 16-03-31 |
Pi Jung Lin
PSD | President | - | 03-06-01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Pi Jung Lin
PSD | President | - | 03-06-01 |
Shu Fang Ou
CHM | Chairman | - | 12-06-27 |
Min Chih Hsiao
BRD | Director/Board Member | 64 | 12-06-27 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 4 M€ | -4.41% | - | |
| 0.00% | 117 M€ | +0.68% | - | |
| 0.00% | 34 M€ | +2.35% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-24 | 245 | +0.62% | 343,099 |
| 24-04-23 | 243.5 | +3.18% | 491,808 |
| 24-04-22 | 236 | -4.26% | 714,594 |
| 24-04-19 | 246.5 | -3.52% | 685,975 |
| 24-04-18 | 255.5 | -1.73% | 265,332 |
End-of-day quote Taipei Exchange, April 23, 2024
More quotes
UNIVERSAL VISION BIOTECHNOLOGY CO., LTD is a Taiwan-based company principally engaged in the trading of ophthalmic supplies and the provision of eye treatment and related medical services. The Company provides laser vision correction equipment and services, as well as the trading of medical drugs, optical glasses and contact lenses. In addition, the Company is involved in the leasing of medical places, the planning of clinic operation, as well as the provision of medical cosmetology services. The Company operates its businesses mainly in Taiwan market.
Calendar
2024-05-08
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
245
TWD
Average target price
313.8
TWD
Spread / Average Target
+28.06%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -11.55% | 636M | |
| +10.79% | 39.29B | |
| -4.66% | 17.93B | |
| -23.47% | 2.14B | |
| -7.23% | 1.55B | |
| +22.95% | 1.16B | |
| -35.29% | 744M | |
| -37.31% | 730M | |
| +20.00% | 477M | |
| +11.29% | 466M |
- Stock Market
- Equities
- 3218 Stock
